These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 20067021)
1. [Neuroprotective effects and mechanisms of Chuanxiong Chatiao pulvis against MPTP-induced dopaminergic neurotoxicity in mice model of Parkinson's disease]. Shu D; He J; Chen J Zhongguo Zhong Yao Za Zhi; 2009 Oct; 34(19):2494-7. PubMed ID: 20067021 [TBL] [Abstract][Full Text] [Related]
2. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice. Sakai R; Irie Y; Murata T; Ishige A; Anjiki N; Watanabe K Phytother Res; 2007 Sep; 21(9):868-73. PubMed ID: 17486689 [TBL] [Abstract][Full Text] [Related]
3. [Effect of the oil from ganoderma lucidum spores on pathological changes in the substantia nigra and behaviors of MPTP-treated mice]. Zhu WW; Liu ZL; Xu HW; Chu WZ; Ye QY; Xie AM; Chen L; Li JR Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):667-71. PubMed ID: 15958304 [TBL] [Abstract][Full Text] [Related]
4. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions. Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176 [TBL] [Abstract][Full Text] [Related]
5. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Liu LX; Chen WF; Xie JX; Wong MS Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104 [TBL] [Abstract][Full Text] [Related]
7. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118 [TBL] [Abstract][Full Text] [Related]
8. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity. Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147 [TBL] [Abstract][Full Text] [Related]
10. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265 [TBL] [Abstract][Full Text] [Related]
11. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice. Hong Z; Wang G; Gu J; Pan J; Bai L; Zhang S; Chen SD Eur J Neurosci; 2007 Sep; 26(6):1500-8. PubMed ID: 17714494 [TBL] [Abstract][Full Text] [Related]
12. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains. Haobam R; Sindhu KM; Chandra G; Mohanakumar KP Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease. Schmidt N; Ferger B Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221 [TBL] [Abstract][Full Text] [Related]
14. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice. Leng A; Mura A; Hengerer B; Feldon J; Ferger B Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025 [TBL] [Abstract][Full Text] [Related]
15. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice. Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotection in Parkinson models varies with toxin administration protocol. Anderson DW; Bradbury KA; Schneider JS Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378 [TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation. Li R; Peng N; Du F; Li XP; Le WD Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):376-80. PubMed ID: 16624731 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817 [TBL] [Abstract][Full Text] [Related]
19. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Jourdain S; Morissette M; Morin N; Di Paolo T J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Shin JY; Park HJ; Ahn YH; Lee PH J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]